PERTZYE

Digestive Care, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 11, 2024
Approval ID: 481eec00-9abf-11dd-b71c-0002a5d5c51b
Products: 0 registered
Version: 22

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"br": [null, null, null], "#text": "These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. \n PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 2012"}

Quick Stats

Total Products0

Labelers1

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.